Edition:
United States

Pfizer Inc (PFE.N)

PFE.N on New York Stock Exchange

42.09USD
17 Aug 2018
Change (% chg)

$0.67 (+1.62%)
Prev Close
$41.42
Open
$41.49
Day's High
$42.19
Day's Low
$41.47
Volume
7,625,026
Avg. Vol
6,502,203
52-wk High
$42.19
52-wk Low
$32.33

Chart for

About

Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development and manufacture of healthcare products. Its global portfolio includes medicines and vaccines, as well as consumer healthcare products. The Company manages its commercial operations through two business... (more)

Overall

Beta: 0.95
Market Cap(Mil.): $246,736.20
Shares Outstanding(Mil.): 5,862.11
Dividend: 0.34
Yield (%): 3.23

Financials

  PFE.N Industry Sector
P/E (TTM): 19.28 28.29 30.45
EPS (TTM): 2.18 -- --
ROI: 9.65 12.92 12.63
ROE: 20.52 14.94 14.82

Pfizer bets on biotech flu vaccine in $425 million BioNTech alliance

FRANKFURT Pfizer has agreed to pay German biotech firm BioNTech up to $425 million in an alliance to develop more effective influenza jabs, the latest among several major pharma companies to bank on a promising new genetic approach.

Aug 16 2018

Pfizer bets on biotech flu vaccine in $425 mln BioNTech alliance

FRANKFURT, Aug 16 Pfizer has agreed to pay German biotech firm BioNTech up to $425 million in an alliance to develop more effective influenza jabs, the latest among several major pharma companies to bank on a promising new genetic approach.

Aug 16 2018

J&J loses bid to dismiss Pfizer antitrust case over Remicade

A federal judge on Friday rejected Johnson & Johnson's bid to dismiss a lawsuit by Pfizer Inc claiming that the drugmaker had engaged in an anticompetitive scheme to shield its blockbuster rheumatoid arthritis drug Remicade from competition.

Aug 10 2018

Allergan sues Pfizer over costs of opioid litigation

Allergan Plc on Thursday sued Pfizer Inc to require its rival to cover any damages it is forced to pay as a result of hundreds of lawsuits claiming Allergan deceptively marketed an opioid it acquired from a company Pfizer bought.

Aug 02 2018

UPDATE 1-Allergan sues Pfizer over costs of opioid litigation

Aug 2 Allergan Plc on Thursday sued Pfizer Inc to require its rival to cover any damages it is forced to pay as a result of hundreds of lawsuits claiming Allergan deceptively marketed an opioid it acquired from a company Pfizer bought.

Aug 02 2018

CORRECTED-Allergan sues Pfizer over costs of opioid litigation

Aug 2 Allergan Plc on Thursday sued Pfizer Inc to force its rival to cover any damages Allergan is forced to pay as a result of hundreds of lawsuits claiming it deceptively marketed an opioid it acquired from a company Pfizer bought.

Aug 02 2018

Pfizer CEO expects Trump to eliminate drug rebates

Pfizer Inc Chief Executive Ian Read said on Tuesday he believes the Trump administration intends to stop the practice of allowing rebates on prescription drug purchases, suggesting that U.S. drug pricing reforms may focus on middlemen rather than drugmakers. | Video

Jul 31 2018

Pfizer CEO believes U.S. will eliminate rebates on prescription drugs

NEW YORK Pfizer Inc Chief Executive Ian Read said on Tuesday that he believes the Trump administration intends to eliminate rebates on prescription drug purchases, but he does not know how quickly such a policy could be implemented.

Jul 31 2018

UPDATE 4-Pfizer CEO expects Trump to eliminate drug rebates

July 31 Pfizer Inc Chief Executive Ian Read said on Tuesday he believes the Trump administration intends to stop the practice of allowing rebates on prescription drug purchases, suggesting that U.S. drug pricing reforms may focus on middlemen rather than drugmakers.

Jul 31 2018

Pfizer CEO believes U.S. will eliminate rebates on prescription drugs

NEW YORK, July 31 Pfizer Inc Chief Executive Ian Read said on Tuesday that he believes the Trump administration intends to eliminate rebates on prescription drug purchases, but he does not know how quickly such a policy could be implemented.

Jul 31 2018

Competitors

  Price Chg
Johnson & Johnson (JNJ.N) $134.47 +1.99
Novartis AG (NOVN.S) CHF82.48 +0.76
Merck & Co., Inc. (MRK.N) $69.06 +0.21
Roche Holding Ltd. (ROG.S) CHF239.95 +0.75
Roche Holding Ltd. (RO.S) CHF243.20 +0.20
Abbott Laboratories (ABT.N) $64.72 +0.56
Bayer AG (BAYGn.DE) €78.40 +1.35
Bayer AG (BAYE.F) -- --
Sanofi SA (SASY.PA) €73.30 +0.64
AstraZeneca plc (AZN.L) 5,930.00 -6.00

Earnings vs. Estimates